MASS

908 Devices Inc. (MASS) | Rumor.io

908 Devices

MASS

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)100%

Price to earnings ratio21.6

Market capitalization482M

Earnings per share-0.95

Dividend yield (TTM)—

Revenue (annual)56.2M

Net income (annual)19.5M

Social

What share of all stock conversation is about MASS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jan 20

908 Devices Inc. (MASS) reported preliminary Q4 revenue of $17.2M, a 20% YoY increase, and FY2025 revenue of $56.0M, a 17% YoY increase, beating high end of guidance.
MASS achieved positive Adjusted EBITDA in Q4, marking a strategic pivot to profitability, with the company to release full results and 2026 outlook later this quarter.
MASS stock price surged +14% after the announcement, with trading volume confirming a breakout, and a short-squeeze tailwind present with a short ratio of 8.10 and short float of 12.31%.

Generated by AI

Sentiment

Of the messages about MASS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	98.98% +29.07
Bearish	—	—	—	1.02% -29.07

Bullish· Mar 5

The asset is expected to reach $2.35 by tomorrow, providing an opportunity to sell at a profit and buy back at a lower price on Friday.
The company is experiencing a multi-day upward trend, with the asset reaching a high of $4.48 and potentially continuing to rise.
The asset is expected to have a significant price drop to $2, potentially killing short positions and creating a buying opportunity.

Bearish· Mar 5

$MASS has broken its momentum and is heading south, making a pump impossible.
The stock has no volume, increasing the likelihood of a sell-off unless buyers intervene.
The 3.80 support level must be lost, and the stock must trade below the VWAP to confirm a bearish movement.

Generated by AI

Topics

Of the messages about MASS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	72%
Controversies	—	—	—	1%
Earnings	—	—	—	4%
Macro	—	—	—	0%
Technical Analysis	—	—	—	23%

May 11

908 Devices reports Q1 2022 financial results, reiterating 2022 revenue outlook.
Company announces expansion of research and testing team in Toronto lab.
Latest test data for ATMOFIZER TECHNOLOGIES INC. is announced.

Generated by AI

Community

Of the messages about MASS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	11.3%
Newcomers	—	—	—	88.7%

Regulars· Mar 7

$MASS reported a loss of $0.31, missing the consensus estimate by $0.05, while revenue of $11.64M beat expectations.
908 Devices' GAAP EPS of -$0.31 and revenue of $11.64M were released in the company's 2022 Q4 earnings call presentation.
The company provided a 2023 revenue outlook, reporting revenue of $46.85M for 2022 and a loss of $0.31 in Q4.

Newcomers· Jan 16

Newcomers are focusing on $MASS's strong price performance, with a 10.62% increase in the last 17 minutes.
Investors are taking notice of $MASS's high trading volume, with 216k shares traded in the last 17 minutes.
The catalyst for $MASS's recent price action is seen as the company's upcoming earnings announcement.

Generated by AI

News

908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium

BURLINGTON, Mass., September 01, 2026--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will participate in the upcoming 32nd Annual Gabelli Aerospace & Defense Symposium on September 10, 2026, in New York City.

29d agoYahoo Finance

908 Devices Inc. (MASS) Presents at 17th Annual Midwest IDEAS Conference - Slideshow

1mo agoSeeking Alpha

908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates

908 Devices (NASDAQ:MASS) outlined its strategy to expand in handheld chemical detection following second-quarter 2026 results that showed revenue growth, a narrower adjusted EBITDA loss and increasing recurring revenue. Speaking at the Midwest IDEAS Conference, CEO and Co-Founder Kevin Knopp said

1mo agoYahoo Finance

Also Discussed

Investors talking about MASS also mention

#	Name	Attention
1	Seer, Inc. Class A Common StockSEER	0%0
2	Samfine Creation Holdings Group Ltd. Class A Ordinary SharesSFHG	0%new
3	Haoxi Health Technology Limited Class A Ordinary SharesHAO	0%0
4	Galecto Inc.GLTO	0%0
5	RPTX - Repare Therapeutics Inc.	——
6	BTC Digital Ltd.BTCT	0%0
7	SKK Holdings Ltd Class A Ordinary SharesSKK	0%new
8	Astronics CorporationATRO	0%0
9	Gaxos.ai Inc.GXAI	0%0
10	The Joint Corp.JYNT	0%0

908 Devices Inc.

Healthcare
Medical Devices

908 Devices Inc. is a medical technology company that develops handheld and desktop chemical analysis instruments for point-of-need testing. Its product portfolio centers on portable mass spectrometry and spectroscopy systems used to detect, identify, and monitor unknown substances in demanding environments. The company’s devices support applications across health, safety, and defense, including field screening for hazardous chemicals, drugs, explosives, gases, and other materials that require rapid analysis outside traditional laboratories. 908 Devices also serves markets such as life sciences research, bioprocessing, biopharma, forensics, and industrial analysis with tools designed for faster, more accessible sample interrogation. Headquartered in Burlington, Massachusetts, 908 Devices focuses on making advanced analytical capabilities available in compact formats that can be used directly at the point of need.

Website

Location

44 3rd Avenue

Burlington, MA, 01803

United States

Social

What share of all stock conversation is about MASS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jan 20

908 Devices Inc. (MASS) reported preliminary Q4 revenue of $17.2M, a 20% YoY increase, and FY2025 revenue of $56.0M, a 17% YoY increase, beating high end of guidance.
MASS achieved positive Adjusted EBITDA in Q4, marking a strategic pivot to profitability, with the company to release full results and 2026 outlook later this quarter.
MASS stock price surged +14% after the announcement, with trading volume confirming a breakout, and a short-squeeze tailwind present with a short ratio of 8.10 and short float of 12.31%.

Generated by AI

Sentiment

Of the messages about MASS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	98.98% +29.07
Bearish	—	—	—	1.02% -29.07

Bullish· Mar 5

The asset is expected to reach $2.35 by tomorrow, providing an opportunity to sell at a profit and buy back at a lower price on Friday.
The company is experiencing a multi-day upward trend, with the asset reaching a high of $4.48 and potentially continuing to rise.
The asset is expected to have a significant price drop to $2, potentially killing short positions and creating a buying opportunity.

Bearish· Mar 5

$MASS has broken its momentum and is heading south, making a pump impossible.
The stock has no volume, increasing the likelihood of a sell-off unless buyers intervene.
The 3.80 support level must be lost, and the stock must trade below the VWAP to confirm a bearish movement.

Generated by AI

Topics

Of the messages about MASS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	72%
Controversies	—	—	—	1%
Earnings	—	—	—	4%
Macro	—	—	—	0%
Technical Analysis	—	—	—	23%

May 11

908 Devices reports Q1 2022 financial results, reiterating 2022 revenue outlook.
Company announces expansion of research and testing team in Toronto lab.
Latest test data for ATMOFIZER TECHNOLOGIES INC. is announced.

Generated by AI

Community

Of the messages about MASS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	11.3%
Newcomers	—	—	—	88.7%

Regulars· Mar 7

$MASS reported a loss of $0.31, missing the consensus estimate by $0.05, while revenue of $11.64M beat expectations.
908 Devices' GAAP EPS of -$0.31 and revenue of $11.64M were released in the company's 2022 Q4 earnings call presentation.
The company provided a 2023 revenue outlook, reporting revenue of $46.85M for 2022 and a loss of $0.31 in Q4.

Newcomers· Jan 16

Newcomers are focusing on $MASS's strong price performance, with a 10.62% increase in the last 17 minutes.
Investors are taking notice of $MASS's high trading volume, with 216k shares traded in the last 17 minutes.
The catalyst for $MASS's recent price action is seen as the company's upcoming earnings announcement.

Generated by AI

908 Devices

Social

Jan 20

Bullish· Mar 5

Bearish· Mar 5

May 11

Regulars· Mar 7

Newcomers· Jan 16

Awm investment sells $283k in 908 Devices stock By Investing.com

Canaccord initiates 908 Devices stock coverage with buy rating

908 Devices: director Brown sells $317,400 of common stock

908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium

908 Devices Inc. (MASS) Presents at 17th Annual Midwest IDEAS Conference - Slideshow

908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates

Also Discussed

908 Devices Inc.

Company Information

Location

Awm investment sells $283k in 908 Devices stock By Investing.com

Canaccord initiates 908 Devices stock coverage with buy rating

908 Devices: director Brown sells $317,400 of common stock

908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium

908 Devices Inc. (MASS) Presents at 17th Annual Midwest IDEAS Conference - Slideshow

908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates

Also Discussed

Social

Jan 20

Bullish· Mar 5

Bearish· Mar 5

May 11

Regulars· Mar 7

Newcomers· Jan 16